These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12019862)

  • 1. ICJ 3393: a new lodinated nonionic low osmolal dimer with low viscosity as contrast agent for X-ray.
    Riefke B; González L; Carretero J; González C; Jimenéz I; Alguacil LF; Böhle F; Martin F; Martin JL
    Acad Radiol; 2002 May; 9 Suppl 1():S178-81. PubMed ID: 12019862
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary carboxamides. Nonionic isotonic monomers.
    Sovak M; Terry RC; Douglass JG; Schweitzer L
    Invest Radiol; 1991 Nov; 26 Suppl 1():S159-61; discussion S165-6. PubMed ID: 1808115
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of iodinated contrast agent properties on renal kinetics and oxygenation.
    Lenhard DC; Frisk AL; Lengsfeld P; Pietsch H; Jost G
    Invest Radiol; 2013 Apr; 48(4):175-82. PubMed ID: 23262792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast nephropathy: isosmolar and low-osmolar contrast media.
    Detrenis S; Meschi M; Savazzi G
    J Am Coll Cardiol; 2007 Feb; 49(8):922; author reply 922-3. PubMed ID: 17320755
    [No Abstract]   [Full Text] [Related]  

  • 5. Experience with iodixanol, a new nonionic dimeric contrast medium. Preliminary results from the human phase I study.
    Nossen JO; Aakhus T; Berg KJ; Jørgensen NP; Andrew E
    Invest Radiol; 1990 Sep; 25 Suppl 1():S113-4. PubMed ID: 2283223
    [No Abstract]   [Full Text] [Related]  

  • 6. [Iodixanol. A new isotonic x-ray contrast medium].
    Nossen JO; Andrew E; Aakhus T; Berg KJ; Jørgensen NP
    Tidsskr Nor Laegeforen; 1991 Apr; 111(9):1108-11. PubMed ID: 2024256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration.
    Lasser EC; Lyon SG; Berry CC
    Radiology; 1997 Jun; 203(3):605-10. PubMed ID: 9169676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The new nonionic contrast preparation for myelography iotrolan].
    Sviridov NK
    Zh Vopr Neirokhir Im N N Burdenko; 1994; (2):35-6. PubMed ID: 8209595
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac events after low osmolar ionic or isosmolar nonionic contrast media utilization in the current era of coronary angioplasty.
    Le Feuvre C; Batisse A; Collet JP; Batisse JP; Choussat R; Beygui F; Helft G; Montalescot G; Metzger JP
    Catheter Cardiovasc Interv; 2006 Jun; 67(6):852-8. PubMed ID: 16649230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety of the currently available iodinated radiopaque contrast agents].
    Poliaev IuA; Shimanovskiĭ NL
    Vestn Rentgenol Radiol; 2010; (4):48-56. PubMed ID: 22187911
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute kidney damage induced by low- and iso-osmolar contrast media in rats: Comparison study with physiologic MRI and histologic-gene examination.
    Wu CJ; Bao ML; Wang Q; Wang XN; Liu XS; Shi HB; Zhang YD
    J Magn Reson Imaging; 2017 Jan; 45(1):291-302. PubMed ID: 27367527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiography with nonionic X-ray contrast media in severe chronic renal failure: renal function and contrast retention.
    Jakobsen JA; Berg KJ; Kjaersgaard P; Kolmannskog F; Nordal KP; Nossen JO; Rootwelt K
    Nephron; 1996; 73(4):549-56. PubMed ID: 8856250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adverse reactions to contrast media for intravenous use. A comparison between ionic and nonionic media].
    Urrutia M; Macharaviaya A; Rodríguez R
    Rev Med Panama; 1995; 20(1-2):20-4. PubMed ID: 7480899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nonionic monomeric and dimeric contrast media on the twitching reaction of the rat. Importance of osmolality and electrolyte content.
    Bååth L; Besjakov J; Pettersson G
    Invest Radiol; 1994 Nov; 29(11):985-9. PubMed ID: 7890513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iodinated contrast media and contrast-induced nephropathy: is there a preferred cost-effective agent?
    Sharma SK
    J Invasive Cardiol; 2008 May; 20(5):245-8. PubMed ID: 18460711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of renal and hepatic impairment by ionic and nonionic contrast media.
    Langer M; Langer R; Felix R; Speck U; Behrends B; Mützel W
    Invest Radiol; 1990 Sep; 25 Suppl 1():S125-6. PubMed ID: 2283230
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute severe thrombocytopenia following non-ionic low-osmolarity intravenous contrast medium injection.
    Bata P; Tarnoki AD; Tarnoki DL; Horvath E; Berczi V; Szalay F
    Korean J Radiol; 2012; 13(4):505-9. PubMed ID: 22778575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical parameters of x-ray contrast media.
    Krause W; Miklautz H; Kollenkirchen U; Heimann G
    Invest Radiol; 1994 Jan; 29(1):72-80. PubMed ID: 8144342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iosimenol, a low-viscosity nonionic dimer: preclinical physicochemistry, pharmacology, and pharmacokinetics.
    Sovak M; Terry R; Abramjuk C; Faberová V; Fiserova M; Laznicek M; Leuschner J; Malinak J; Zahradnik P; Masner O; Seligson A
    Invest Radiol; 2004 Mar; 39(3):171-81. PubMed ID: 15076009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal safety of iodixanol.
    McCullough PA
    Expert Rev Cardiovasc Ther; 2006 Sep; 4(5):655-61. PubMed ID: 17081087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.